Tianjin Zhongxin Pharmaceutical Group Corp Ltd - Asset Resilience Ratio

Latest as of September 2025: 5.92%

Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has an Asset Resilience Ratio of 5.92% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Tianjin Zhongxin Pharmaceutical Group Co PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥685.28 Million

≈ $100.28 Million USD Cash + Short-term Investments

Total Assets

CN¥11.59 Billion

≈ $1.70 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how Tianjin Zhongxin Pharmaceutical Group Corp Ltd's Asset Resilience Ratio has changed over time. See Tianjin Zhongxin Pharmaceutical Group Co (600329) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Tianjin Zhongxin Pharmaceutical Group Corp Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Tianjin Zhongxin Pharmaceutical Group Co worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥685.28 Million	5.92%
Total Liquid Assets	CN¥685.28 Million	5.92%

Asset Resilience Insights

Limited Liquidity: Tianjin Zhongxin Pharmaceutical Group Corp Ltd maintains only 5.92% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Industry Peers by Asset Resilience Ratio

Compare Tianjin Zhongxin Pharmaceutical Group Corp Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Eris Lifesciences Limited NSE:ERIS	Drug Manufacturers - Specialty & Generic	0.58%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Lotus Pharmaceutical Co Ltd TW:1795	Drug Manufacturers - Specialty & Generic	0.49%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%

Annual Asset Resilience Ratio for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2000–2024)

The table below shows the annual Asset Resilience Ratio data for Tianjin Zhongxin Pharmaceutical Group Corp Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	9.29%	CN¥1.00 Billion ≈ $146.34 Million	CN¥10.77 Billion ≈ $1.58 Billion	+9.09pp
2023-12-31	0.20%	CN¥20.31 Million ≈ $2.97 Million	CN¥10.23 Billion ≈ $1.50 Billion	-0.36pp
2019-12-31	0.55%	CN¥43.52 Million ≈ $6.37 Million	CN¥7.84 Billion ≈ $1.15 Billion	-0.20pp
2018-12-31	0.75%	CN¥53.31 Million ≈ $7.80 Million	CN¥7.11 Billion ≈ $1.04 Billion	-0.77pp
2017-12-31	1.52%	CN¥100.50 Million ≈ $14.71 Million	CN¥6.62 Billion ≈ $968.98 Million	+1.51pp
2016-12-31	0.01%	CN¥660.00K ≈ $96.58K	CN¥6.36 Billion ≈ $930.77 Million	-0.01pp
2015-12-31	0.02%	CN¥1.49 Million ≈ $218.62K	CN¥6.07 Billion ≈ $888.07 Million	-0.95pp
2013-12-31	0.97%	CN¥51.25 Million ≈ $7.50 Million	CN¥5.26 Billion ≈ $770.04 Million	+0.81pp
2005-12-31	0.16%	CN¥6.54 Million ≈ $957.01K	CN¥4.06 Billion ≈ $593.48 Million	-0.04pp
2004-12-31	0.20%	CN¥8.00 Million ≈ $1.17 Million	CN¥3.91 Billion ≈ $572.63 Million	-1.13pp
2003-12-31	1.34%	CN¥50.70 Million ≈ $7.42 Million	CN¥3.80 Billion ≈ $555.64 Million	+1.30pp
2002-12-31	0.04%	CN¥1.14 Million ≈ $166.38K	CN¥3.01 Billion ≈ $440.18 Million	+0.02pp
2001-12-31	0.02%	CN¥424.00K ≈ $62.04K	CN¥2.72 Billion ≈ $397.98 Million	-5.00pp
2000-12-31	5.02%	CN¥126.86 Million ≈ $18.56 Million	CN¥2.53 Billion ≈ $369.87 Million	--

pp = percentage points

About Tianjin Zhongxin Pharmaceutical Group Corp Ltd

SHG:600329 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.16 Billion

CN¥21.57 Billion CNY

Market Cap Rank

#4859 Global

#886 in China

Share Price

CN¥37.84

Change (1 day)

+0.29%

52-Week Range

CN¥32.44 - CN¥50.05

All Time High

CN¥54.12